Wenbin Mo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Wenbin Mo

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Frontiers in Oncology|April 1, 2022

Methylation of SPRED1: A New Target in Acute Myeloid LeukemiaNan Su, Yujiao Wang, Xianglan Lu, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|November 14, 2025

Engineered suppressor T cells overexpressing IFN-α and PD-L1 inhibit GVHD but retain GVL effects in miceYuanyuan Tian, Bei Jia, Che Young Lee, et al.

Blood|October 23, 2023

Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHDYing Wang, Shan He, Gennaro Calendo, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Frontiers in Oncology|April 1, 2022

Methylation of SPRED1: A New Target in Acute Myeloid LeukemiaNan Su, Yujiao Wang, Xianglan Lu, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|November 14, 2025

Engineered suppressor T cells overexpressing IFN-α and PD-L1 inhibit GVHD but retain GVL effects in miceYuanyuan Tian, Bei Jia, Che Young Lee, et al.

Blood|October 23, 2023

Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHDYing Wang, Shan He, Gennaro Calendo, et al.

Pageof 2